# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-284586
Filing Date
2025-11-17
Accepted
2025-11-17 16:01:45
Documents
13
Period of Report
2025-12-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | acet-20251117.htm iXBRL | DEF 14A | 326869
2 | GRAPHIC | img106677955_0.jpg | GRAPHIC | 11570
3 | GRAPHIC | img106677955_1.jpg | GRAPHIC | 195159
4 | GRAPHIC | img106677955_2.jpg | GRAPHIC | 235803
| Complete submission text file | 0001193125-25-284586.txt |  | 1685827

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acet-20251117.xsd | EX-101.SCH | 40863
15 | EXTRACTED XBRL INSTANCE DOCUMENT | acet-20251117_htm.xml | XML | 1293

Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 251490991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)